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Abstract
Background: In the recent years, musculoskeletal ultrasound (MSUS) has been regarded as especially promising in
the assessment of juvenile idiopathic arthritis (JIA), as a reliable method to precisely document and monitor the
synovial inflammation process.
Main content: MSUS is particularly suited for examination of joints in children due to several advantages over
other imaging modalities. Some challenges should be considered for correct interpretation of MSUS findings in
children, due to the peculiar features of the growing skeleton. MSUS in JIA is considered particularly useful for its
ability to detect subclinical synovitis, to improve the classification of patients in JIA subtypes, for the definition of
remission, as guidance to intraarticular corticosteroid injections and for capturing early articular damage. Current
evidence and applications of MSUS in JIA are documented by several authors. Recent advances and insights into
further investigations on MSUS in healthy children and in JIA patients are presented and discussed in the present
review.
Conclusions: MSUS shows great promise in the assessment and management of children with JIA. Nonetheless,
anatomical knowledge of sonographic changes over time, underlying immunopathophysiology, standardization
and validation of MSUS in healthy children and in patients with JIA are still under investigation. Further research
and educational efforts are required for expanding this imaging modality to more clinicians in their daily practice.
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Background
Juvenile idiopathic arthritis (JIA) is the most common
chronic rheumatic disease of childhood and an import-
ant cause of acquired disability in children [1]. Despite
the heterogeneity, all forms of JIA are characterized by
prolonged synovial inflammation that can cause cartil-
age and bone damage, with severe impairment of phys-
ical function and impact on the quality of life. In the
recent years, the availability of powerful and expensive
drugs increased the need to identify patients with a
high likelihood of developing erosive damage early and
patients with a less aggressive disease, so as to institute
the appropriate therapy at and for the most convenient
time. This induced to search for sensitive methods for
reliable documentation and precise monitoring of the
synovial inflammation process [2–4]. Musculoskeletal
ultrasound (MSUS) demonstrated to be a valid and
reliable tool in the assessment of chronic inflammatory
arthropathies in adults [5–7]. Therefore, it has been
regarded as especially promising in the assessment of
joints in children with JIA [8–11].
Advantages of MSUS in children
Though MSUS has some limitations, it is particularly
suited for use in children for several advantages over
other imaging techniques (Table 1). It is quick, it does
not expose the child to ionizing radiation, it does not
require sedation or general anesthesia, it allows for
multisite assessment in the same session, comparison
between symptomatic and asymptomatic sites, dynamic
study, and it is easily repeatable. Moreover, it is well
accepted by both children and their parents, and it is
the only imaging technique that can be coupled with
the conventional approach to patient assessment in the
clinic (Fig. 1).
Challenges with MSUS in children
Like other imaging modalities, MSUS is an operator
dependent imaging technique. Further, it is highly
dependent on the properties and sensitivity of the
machine used, which can range widely (Fig. 2). As in
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adults, MSUS in children requires continuous practice
after appropriate training and has a limited value in
some musculoskeletal areas, such as the axial skeleton.
When dealing with musculoskeletal imaging in child-
hood, it is noteworthy to emphasize the unique feature of
the growing skeleton, which include age-related variation
of the thickness of the articular cartilage and incomplete
ossification. Moreover, in children the epiphysis are vascu-
larized and metaphyseal vessels anastomose with epiphys-
eal vessels through the growth plate. Depending on the
properties and sensitivity of the ultrasound machine,
vascularization in this area can be physiologically detected
by MSUS in healthy children [12], whereas it would be
regarded as pathological in adults. Several pitfalls can lead
the ultrasonographer with little experience in pediatric
joints to embarrassing misinterpretation of images (Fig. 3).
Therefore, the awareness of a high ratio cartilage/bone,
that changes during child growth, and the anatomical
knowledge of the feeding vessels are of foremost value and
cannot be overtaken.
Table 1 Advantages and limitations of musculoskeletal ultrasound (MSUS) compared to magnetic resonance imaging (MRI) and
conventional radiology in children with juvenile idiopathic arthritis
Imaging modality Advantages Limitations




Demonstration of soft tissue inflammation
Direct visualization of cartilage
Early detection of bone erosions
Ability to scan multiple joints in a single session
Support in guidance of procedures (e.g. intra- articular
corticosteroid injections)
Relatively inexpensive
Difficulties in carrying out in case of severe joint limitation
Relatively small field of view
Inability to assess the whole joint space
Acoustic shadowing from overlying bones
Limited value in the assessment of axial skeleton and
temporomadibular joints
Dependency on the properties and sensitivity of the
ultrasound equipment
Need of continuous practice after appropriate training
Reliability, standardization and validation in children under
investigation
MRI Lack of exposure to ionizing radiation
Multiplanar tomographical imaging
Ability to assess the whole joint space
Demonstration of soft tissue inflammation
Direct visualization of cartilage
Early detection of bone erosions
Visualization of bone marrow oedema
High tissue contrast
Suitable for assessment of axial skeleton and temporomadibular
joints
Intravenous contrast agent often required
Possible allergic reaction to contrast agents
General anesthesia required in younger children
Long examination time
Evaluation limited to one target joint







Applicability to all joints
Demonstration of joint space narrowing, disturbances of bone
growth and maturation
Detection of bone erosions
Validated scoring methods in children
Suitable for longitudinal evaluation of damage progression
Low cost
Widespread availability
Exposure to ionizing radiations
Inability to directly visualize cartilage and soft tissue
inflammation
Late detection of bone erosions and joint space narrowing
Projectional superimposition
Fig. 1 MSUS is well accepted by children and their parents, and can be performed as completion of the joint examination during the standard
clinical assessment of the child. Some children have fun during MSUS evaluation, others totally relax and can fall asleep
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Usefulness of MSUS in children
Despite several challenges, MSUS is commonly regarded
as a very useful tool in children, as outlined by the re-
sults of recent national and international surveys among
pediatric rheumatologists [13, 14]. For most of the re-
spondents, MSUS owned particular relevance for the
ability to detect subclinical synovitis and to improve the
classification of patients in JIA subtypes, as guidance to
intraarticular corticosteroid injections and for capturing
early articular damage. In addition, some specific joints
were considered as most suited to be studied by MSUS,
specifically the midfoot, the ankle, the hip, the wrist, the
small joints of hands and feet.
What is the evidence for usefulness of MSUS in JIA?
Subclinical synovitis and tenosynovitis
Arthritis in JIA is so far defined as swelling within a
joint, or limitation in the range of joint movement with
joint pain or tenderness, persistent over time, observed
by a physician, and not due to primarily mechanical
disorders or to other identifiable causes [15]. Currently,
the definition of an oligoarticular or polyarticular involve-
ment is based on the number of active joints. Therefore,
complete joint assessment is mandatory for accurate as-
sessment of the disease. However, in the recent years sev-
eral authors documented a discrepancy between clinical
and MSUS examination in detecting synovitis in JIA. In
our experience, 1664 joints in 32 children with JIA were
evaluated both clinically and with MSUS. A total of 104
(6.3 %) and 167 (10 %) joints had clinical and MSUS syno-
vitis, respectively. Of the 1560 clinically normal joints, 86
(5.5 %) had synovitis on MSUS. The frequency of subclin-
ical synovitis was greater in wrists, PIP, subtalar and foot
joints [16]. Haslam et al. compared clinical and MSUS
evaluation in 680 joints of 17 patients with early
(<12 months) oligoarticular JIA. Six children had subclin-
ical synovitis, more frequently detected in the small joints
of hands and feet [17]. Other authors reported similar
findings in the assessment of peripheral joints and the
ankle [18–20]. In particular, Rooney at al. observed that
the clinical examination might not be able to distinguish
whether joint swelling in the ankle is due to synovitis,
tenosynovitis or both (Fig. 4). In 34 JIA patients who had
clinically detected swelling in 49 ankles they evaluated the
prevalence of MSUS synovitis and tenosynovitis. Only
29 % of ankles had tibiotalar effusion alone, whereas teno-
synovitis associated with tibiotalar synovitis and tenosyno-
vitis alone were detected in 71 and 39 % of ankles,
respectively. Concomitant tenosynovitis and tibiotalar ef-
fusion were found in 33 % of ankles [20]. In another study
of the same group, 32 % of the ankles considered clinically
involved did not show MSUS synovitis. In 42 % of ankles
recorded as clinically normal MSUS detected involvement
of medial tendons, whereas less than 50 % of the lateral
tendons deemed to be clinically involved were affected on
MSUS [21].
These findings highlight that clinical examination in
JIA may underestimate the extension of synovitis and
sometimes cannot be precise, whereas MSUS can im-
prove the sensitivity and the accuracy in the detection of
the exact sites of inflammation in the joint. Therefore,
implementation of clinical examination with MSUS in
children with JIA can lead to important implications in
therapeutic decisions (i.e. indication to a second line
drug or biologic treatment, or exact location of intraarti-
cular corticosteroid injections) and for monitoring treat-
ment efficacy.
Enthesitis
Enthesitis represents the main feature of the enthesitis-
related arthritis (ERA) JIA subgroup, according to
the International League of Associations for Rheumatol-
ogy (ILAR) classification of JIA, and is clinically defined
as tenderness at the insertion of a tendon, ligament, joint
Fig. 2 Longitudinal scan of the suprapatellar recess in two 7 years
old boys performed with high multifrequency probe: a. Top-level
ultrasound machine in the early 2000’s; b. Top-level ultrasound
machine in 2015
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Fig. 4 A 10 years old girl with JIA presented with mild swelling of the left ankle, without tenderness/pain on motion or limitation on motion.
MSUS showed no signs of synovitis at the tibiotalar joint (a), and allowed detection of a hypo-anechoic halo around the medial tendons (b) and
pathologic vascularization on power Doppler along both the posterior tibialis tendon (c) and the common flexor digiti tendon (d), indicating
flourishing tenosynovitis. PTT: posterior tibialis tendon; CDT: common flexor digitorum tendon; A: posterior tibialis artery; V: posterior tibialis vein
Fig. 3 Metaphysis (M) look like erosions; epiphysis (E) and unossified bones are anechoic, like synovial effusion (a,b). Physiological vascularization at
insertion of enthesis to the cartilage can be frequently detected, resembling enthesitis (c). Feeding vessels can be intraarticular or close to ossifying
nuclei, and must not be considered as signs of active synovitis (d). a. Dorsal longitudinal scan of the II metacarpophalangeal joint in a 2 years old child,
grey-scale. b. Longitudinal medial scan of the suprapatellar recess in a 2 years old child, grey-scale. c. Longitudinal scan of the Achilles tendon at insertion
to the calcaneus in a 5 years old child, power Doppler d. Longitudinal medial scan of the suprapatellar recess in a 5 years old child, power Doppler
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capsule, or fascia to bone [15]. The clinical demonstra-
tion of enthesitis in children is challenging owing to the
peculiar fat distribution, that can mask the anatomical
landmarks, and the frequently insufficient cooperation of
very young children. A recent study reported on MSUS
sensitivity to detect enthesitis in children with JIA [22].
The authors compared physical examination and power
Doppler (PD) MSUS in detecting enthesitis in five sites
(the quadriceps tendon insertion, the proximal and the
distal patellar ligament insertion on the tibial tuberosity,
the Achilles tendon insertion on the posterior surface of
the calcaneus, and the plantar fascia insertion) in 26 pa-
tients with JIA and 41 healthy children. None of the
healthy children had PD MSUS evidence of enthesitis. In
patients with JIA physical examination showed enthesitis
at only 12.5 % of sites, whereas PD MSUS enthesitis was
found at 9.4 % of the investigated sites. Clinical enthesi-
tis was often associated with PD MSUS enthesitis. On
the other hand, 50 % of the sites exhibiting PD MSUS
were clinically normal. Of note, 20 % of the sites with
PD MSUS enthesitis were in patients with oligoarticular
JIA and 10 % in patients with polyarticular JIA.
Recent studies confirmed a higher sensitivity of MSUS
in comparison with clinical examination in detecting
enthesitis in different entheseal sites in patients with
ERA-JIA [23, 24].
These findings overall indicate that MSUS may help
to detect clinically silent peripheral enthesitis in ERA
and non-ERA patients, and can contribute substantially
to the correct diagnosis and classification of JIA. On
the other hand, comprehensive knowledge of the ultra-
sonographic appearance of entheses in healthy subjects
during the developmental ages is still under investiga-
tion (Fig. 5) and reliable definitions for normal and
pathological MSUS findings in pediatric entheses need
first to be addressed.
ILAR classification JIA subgroups
The most recent ILAR classification criteria for JIA were
developed to delineate homogeneous subtypes of JIA for
research purposes [15] and so far have been adopted to
stratify patients and select candidates to second-line
treatment or biologic therapy [25–31]. In particular, chil-
dren with JIA are classified as having oligoarthritis or
polyarthritis based on the number of affected joints; the
presence of active arthritis in at least five joints is a
requisite for the definition of a polyarticular disease
course and for the eligibility to second-line or biologic
agents in several health systems. As already mentioned,
MSUS demonstrates higher sensitivity in detecting syno-
vitis than the clinical examination, and, as a conse-
quence, can lead to reclassify patients, with a trend
towards a more extensive joint involvement and poten-
tial more aggressive therapy. In the author’s experience,
of 32 children with JIA evaluated cross-sectionally both
with clinical and MSUS examinations, five patients, clas-
sified as having mono/oligoarthritis involvement by clin-
ical examination, showed a polyarthritis involvement
based on MSUS findings [16]. Similarly, one patient out
of 17 children with oligoarticular JIA was reclassified as
having polyarthritis after MSUS examination by Haslam
et al. [17]. Of note, MSUS could precisely identify in-
flammatory tendon involvement in JIA patients with
ankle arthritis, as outlined by Rooney at al [20, 21].
Though tendons can be affected throughout the whole
course of JIA, the current ILAR classification does not
take into consideration tendon involvement. Further,
MSUS enthesitis could be found in both in ERA and
non-ERA-JIA patients, as mentioned above [22–24].
Overall these findings suggest that the use of MSUS
may yield important insights in the location of inflam-
matory changes in joints and in different JIA subtypes,
providing the anatomic rationale for a future refinement
of the classification of childhood arthritis.
Definition of disease remission
It has been recently argued that remission of JIA defined
on clinical grounds does not couple with remission defined
with imaging [32–34]. However, the clinical significance
Fig. 5 Sonographic appearance of the patellar enthesis at different
ages. a. 2 years old girl; b. 8 years old girl; c. 10 years old boy. DPT:
distal patellar tendon
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and prognostic value of this finding is unclear, as the
presence of MSUS abnormalities, including PD signal,
in patients with clinically defined inactive disease did
not predict subsequent synovitis flare [35]. This finding
contrasts with observations in adults with rheumatoid
arthritis (RA), in which vascularization detected by PD
MSUS predicted shortterm disease flare after clinical
remission [36, 37].
These puzzling MSUS features may be due to under-
lying immunopathological mechanism and local changes
peculiar of JIA, still unknown and different to the clas-
sical autoinflammatory process in seropositive RA [38].
Future research oriented to explore this supposition and
correlation of MSUS with biologic markers of disease ac-
tivity [39, 40] is advisable.
Imaging guided injections
Intra-articular corticosteroid injections (IACI) are widely
used in JIA to induce prompt relief of symptoms of ac-
tive synovitis. Blind-method is sometimes difficult in the
younger, due to the small joint size and the subcutane-
ous fat masking bony landmarks. Therefore MSUS may
represent a fundamental tool, not only for the precise
detection of the inflamed area, but also for the accurate
placement of the needle tip within the different affected
anatomical structures, in order to maximize the treat-
ment efficacy and minimize local side effects (mainly
subcutaneous atrophy or local skin hypopigmentation)
[41] (Fig. 6). Several authors documented the correct
needle placement and the efficacy of MSUS-guided in-
jections of clinically difficult to access joints, such as the
hip [42], or clinically difficult to assess joints, such as
the ankle and the midfoot [43]. In particular, Laurell at
al. performed MSUS-guided IACI in 85 compartments
of the ankle, including twenty-one tendon sheaths and a
ganglion cyst, and observed normalization or regression
of MSUS-detected synovial hypertrophy in 89 % of the
injected sites at 4 weeks after IACI. The same authors
also reported on the efficacy of MSUS-guided IACI in
21 compartments of 15 wrists, with increasing improve-
ment of synovial hypertrophy and synovial hyperemia at
1 week and 4 weeks post-injection [44]. Another joint
that can particularly benefit from MSUS-guided IACI is
the temporomadibular joint (TMJ). Efficacy and safety
assessed 6–8 weeks post MSUS-guided injection of 63
TMJ in 39 children with JIA showed improvement in all
symptoms and only one side effect (local scar) in one pa-
tient [45]. However, data on correct needle placement in
TMJ by MSUS-guidance are scarce and controversial
[46, 47], and need to be further investigated.
Cartilage damage
Joint cartilage is a known target in inflammatory arth-
ritis. Though MSUS do not allow to visualizing cartilage
in its entireness in all joints, due to its limited acoustic
window, loss of MSUS detected cartilage in “key sites” of
the joints may represent an early marker of damage in
JIA. Spannow, et al were the first to attempt the meas-
urement and quantification of cartilage thickness in
pediatric subjects [48]. They provided normal ranges of
MSUS-detected cartilage thickness in small and large
joints of healthy children, and designed a complicated
formula in order to calculate cartilage thickness in the
clinically dominant joints for different age groups of
children [49]. Cartilage was found significantly thicker in
boys than in girls and diminished progressively with age
in both sexes, as similarly reported later by other authors
[50]. The same investigators provided data on intra- and
interobserver agreement and validated MSUS measure-
ment of cartilage thickness in several joints of healthy
children by comparing MSUS with findings obtained
with magnetic resonance imaging (MRI), with an overall
good agreement except for the wrist [51, 52]. In a subse-
quent study, Spannow and coworkers measured cartilage
thickness with MSUS in joints of patients with JIA, and
compared the findings with those obtained in healthy
children. Of note, cartilage thickness in joints of patients
Fig. 6 MSUS allows detection of the exact location of inflammation
and correct needle placement, even in very small sites, such as the
synovial sheath of the flexor tendon of the VI digit in a 3 years old
girl. NT: needle tip; FDT: flexor digiti tendon; SE: synovial effusion
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with JIA was significantly lower than in the healthy cohort,
regardless of whether the examined joints have been pre-
viously affected by arthritis [53]. Pradsgaard, et al. from
the same group of investigators, compared MSUS and
MRI measurements of distal femoral cartilage thickness in
children with JIA. They identified the intercondylar notch
as the best site to assess cartilage thickness, because of its
easier assessment and lower variability on MSUS as com-
pared to MRI [54]. These findings may support that irre-
versible changes can occur in cartilage of children with
JIA despite the localization of synovial inflammation. The
measurement of cartilage thickness at the intercondylar
notch of the knee may act as a surrogate of overall early
cartilage damage in JIA patients. However, since MSUS
and MRI cartilage measurements at different sites of the
knee were problematic in the previously affected and
unaffected knees compared to the whole cohort, this pro-
posal is controversial [55]. Thorough studies in patients
with long term inactive and active JIA and comparison with
the newer MRI techniques for the biochemical evaluation
of cartilage matrix composition over time [56] would give
insights to address these challenging issues.
Bone erosions
Compared with conventional radiography, the capacity
to assess dynamically and in real-time the joints in sev-
eral planes makes MSUS a more useful tool for detecting
erosions [57, 58]. The OMERACT (Outcome Measures
in Rheumatology Clinical Trials) definitions of bone ero-
sion require documenting an interruption of the intraar-
ticular bone surface or cortical breaks with a step-off
bone defect visible in at least two perpendicular planes
[59]. However, children anatomy is characterized by
physiological bone irregularities due to the presence of
ossification centers and growth plates at the epiphyseal
cartilage. Moreover, when ossified, some bones can at
first appear fragmented and irregular (Fig. 7). Conse-
quently, in children all these peculiar normal findings
may potentially be misinterpreted as cortical erosions by
inexperienced operator eyes. Further, due to the peculiar
vascularization of the epiphysis in children, that anasto-
moses with metaphyseal vessels through the growth
plate, an inflammation affecting the epiphyseal cartilage
may spread to the ossification center, causing excessive
growth, deformities, or destruction with epiphyseal ero-
sions rather than marginal erosions, unlike RA patients.
These observations advise that further validation and
large-scale studies are required to determine the poten-
tial role and the accuracy of MSUS in the detection of
bone damage in children.
Advances and perspectives
At present, increasing interest in the use of MSUS dur-
ing daily clinical practice is spreading among pediatric
rheumatologists. Nonetheless, several topics are still
under investigation or need to be further addressed.
First of all, the anatomical specificities of the growing
skeleton in children make imaging interpretation more
challenging than in adults and thorough knowledge of
the sonoanatomy changes at the different growth ages
is essential to distinguish physiological appearance from
pathological findings. Recently, definitions for gray
scale sonographic features of joints in healthy children
have been proposed and validated [60]. Sonographic ap-
pearance of tendons, entheses and Doppler MSUS in
healthy children was not described and requires specific
additional studies. Secondly, in the recent years several
investigators proposed to assess children using standard
scans according to the EULAR (European League Against
Rheumatism) guidelines [61]. However, this scanning
approach has been developed for MSUS examination of
adults, and its applicability and reliability in children
were not demonstrated. In the frame of the OMERACT
Ultrasound pediatric subtask force, Collado et al. set up
Fig. 7 The calcaneus bone appears fragmented in children
respectively aged 6 years (a), 8 years (b), and 10 years (c). Feeding
vessels can be detected by power Doppler (red dots)
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a standardized MSUS examination method specific for
the pediatric population [12]. The study showed a high
quality of images obtained by all the investigators, des-
pite the use of different sonographic equipments, indi-
cating suited methodology. MSUS standard scans
proposed were appropriate and reproducible in children
regardless of their age. Further, the standardized MSUS
examination, together with the MSUS definitions of
normal features in pediatric joints, enabled the investi-
gators to achieve information on physiological blood
flow and on age-related changes of bones in each joint.
The next step would be standardization of findings in
synovitis and in abnormal vascularization detected by
Doppler, and is already ongoing.
Studies in adults with RA have recommended the use
of reduced and simplified joint counts for MSUS as-
sessment of disease activity, preventing in this way too
long-lasting evaluations [62, 63]. This may be particu-
larly relevant in children, since they notoriously are less
tolerant than adults of undergoing investigations. Re-
cently, some investigators proposed a reduced joint PD
MSUS assessment and provided preliminary evidence
of its validity, reliability, sensitivity to change and feasi-
bility in evaluating synovitis in JIA [64]. Nonetheless,
these results should be confirmed in independent co-
horts with large number of patients. Additional studies
in children with JIA in order to define the pattern and
number of joints to be assessed with MSUS, both with
grey scale and Doppler, are warranted.
Although there is an astounding interest in the appli-
cation of MSUS in children, only few pediatric rheuma-
tologists are able to perform MSUS on their own, as
outlined by recent surveys [13, 14]. On the other hand,
most of the respondents to the surveys stated their will-
ingness to embrace this imaging modality and to gain
experience in performing MSUS by themselves. There-
fore, access to suitable training and mentorship for
MSUS in children is of primary relevance. Further edu-
cational activities are required to enhance the use of this
imaging modality in pediatric rheumatologists’ practice.
Conclusions
MSUS shows great promise in the assessment and man-
agement of children with JIA, so that it is likely to play
an increasing role in clinical practice of pediatric rheu-
matologists, as in adult rheumatology. However, several
issues, including the anatomical knowledge of sono-
graphic changes over time and the underlying immuno-
pathophysiology, the standardization and validation of
MSUS in healthy children and in patients with JIA, are
still under investigation. Currently, few pediatric rheu-
matologists are able to perform MSUS on their own. In
the future further research and educational efforts are
required for expanding this imaging modality to more
clinicians in their daily practice.
Key points
 MSUS can detect inflammatory changes more
frequently than the clinical examination and can
visualize their exact location in joints of children
with different JIA ILAR subtypes, yielding important
insights in the extent, pathophysiology and
classification of childhood arthritis.
 Due to the unique features of the growing skeleton,
accurate knowledge of MSUS findings over time in
children is warranted. Currently, validated
definitions of MSUS features in joints of healthy
children are available; standardization of scanning
techniques specific for the pediatric population and
definitions of MSUS pathological findings in
children are ongoing.
 Correlation of MSUS findings with biologic markers,
clinical features and other imaging tools should be
studied prospectively to investigate the clinical
meaning and prognostic value of MSUS-detected
abnormalities in different joints at different time
points of the disease course.
 Despite the astounding interest in the use of MSUS
in children, only few pediatric rheumatologists
currently perform MSUS on their own. Further
educational activities for suitable training and
mentorship in MSUS in children are advisable in
the future.
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